Hims & Hers Super Bowl controversy: What the ad left out...

@LiveScience Compartió un vínculo

2025-02-11 02:44:41 ·

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

www.livescience.com

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

0 Commentarios ·0 Acciones ·63 Views

Please log in to like, share and comment!

Upgrade to Pro

Choose the Plan That's Right for You

Upgrade